Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T C Nichols

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Atherosclerosis|February 12, 2017
An anti-αVβ3 antibody inhibits coronary artery atherosclerosis in diabetic pigsL A Maile, W H Busby, G Xi, et al.
Nature Medicine|January 12, 1999
Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vectorR W Herzog, E Y Yang, L B Couto, et al.
Gene Therapy|January 9, 2004
Intravenous administration of an AAV-2 vector for the expression of factor IX in mice and a dog model of hemophilia BT C Harding, K E Koprivnikar, G H Tu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 12, 2001
Lack of germline transmission of vector sequences following systemic administration of recombinant AAV-2 vector in malesV R Arruda, P A Fields, R Milner, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Atherosclerosis|February 12, 2017
An anti-αVβ3 antibody inhibits coronary artery atherosclerosis in diabetic pigsL A Maile, W H Busby, G Xi, et al.
Nature Medicine|January 12, 1999
Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vectorR W Herzog, E Y Yang, L B Couto, et al.
Gene Therapy|January 9, 2004
Intravenous administration of an AAV-2 vector for the expression of factor IX in mice and a dog model of hemophilia BT C Harding, K E Koprivnikar, G H Tu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 12, 2001
Lack of germline transmission of vector sequences following systemic administration of recombinant AAV-2 vector in malesV R Arruda, P A Fields, R Milner, et al.
Pageof 6